7.3 Pigmentation Disorders & Cutaneous Inflammations

Pigmentation Disorders & Cutaneous Inflammations

Quick Summary: The biological color of human skin is primarily determined by melanin pigment synthesized by basal melanocytes. Any deviation from normal cutaneous coloration is termed a dyschromia. Dyschromias are divided into hyperpigmentation (abnormal pigment overproduction or distribution, including melasma, post-inflammatory hyperpigmentation [PIH], solar lentigines, and ephelides) and hypopigmentation / depigmentation (pigment deficiency or loss, including autoimmune vitiligo, congenital albinism, post-traumatic leukoderma, and fungal tinea versicolor). In parallel, inflammatory cutaneous conditions represent major clinical challenges: rosacea is a chronic neurovascular disorder driven by flushing, telangiectasias, and flares that strictly contraindicates thermal modalities; contact dermatitis spans Type IV delayed allergic hypersensitivity and direct irritant barrier damage; atopic dermatitis (eczema) stems from genetic filaggrin barrier defects; and psoriasis is an autoimmune disease causing accelerated 3- to 4-day keratinocyte turnover and micaceous silvery-scaled plaques.

Mastering the biological triggers and differential diagnosis of these conditions is essential for establishing safe clinical treatment parameters, selecting appropriate chemical peel agents, avoiding post-inflammatory pigment disasters, and safeguarding compromised skin barriers.

---

1. Dyschromia & Melanogenesis Overview

Melanin is produced inside specialized basal epidermal dendritic cells called melanocytes. Within cytoplasmic organelles called melanosomes, the copper-containing enzyme tyrosinase converts the amino acid tyrosine into dopaquinone, synthesizing brown-black eumelanin (photoprotective) or yellow-red pheomelanin (photolabile). Dendritic arms then transfer mature melanosomes into neighboring keratinocytes (1 melanocyte services roughly 36 keratinocytes in the epidermal melanin unit).

+-------------------------------------------------------------------------+
|                         THE DYSCHROMIA SPECTRUM                         |
+=========================================================================+
|  HYPERPIGMENTATION (Excess Melanin)    HYPOPIGMENTATION (Melanin Loss)  |
|  -----------------------------------   -------------------------------  |
|  • Melasma / Chloasma                  • Vitiligo                       |
|    Hormones (Estrogen) + UV/Heat         Autoimmune melanocyte death    |
|    Symmetric "pregnancy mask"            Stark milky-white patches      |
|  • Post-Inflammatory (PIH)             • Albinism                       |
|    Melanocyte trauma response            Congenital tyrosinase absence  |
|    Huge risk in Fitzpatrick IV–VI        Zero melanin: skin/hair/eyes   |
|  • Solar Lentigines ("Sun Spots")      • Leukoderma                     |
|    Cumulative UV damage                  Post-traumatic depigmentation  |
|  • Ephelides (Freckles)                • Tinea Versicolor               |
|    Genetic, darken with UV               Malassezia yeast overgrowth    |
+-------------------------------------------------------------------------+

When melanocyte signaling or enzymatic activity becomes disrupted, the resulting clinical condition is broadly classified as a dyschromia.

---

2. Hyperpigmentation Disorders

Hyperpigmentation results from increased melanin production, an increased number of active melanocytes, or abnormal deposition of melanin pigment into the viable epidermis or upper dermis.

Melasma (Chloasma / "Pregnancy Mask")

Melasma is an acquired, chronic hypermelanosis characterized by symmetric, reticulated, light-to-dark brown or slate-gray macular patches appearing primarily on sun-exposed areas of the face. It displays three classic facial distribution patterns: centrofacial (forehead, nose, upper lip, chin), malar (cheeks), and mandibular:

• Etiological Triggers: Melasma is driven by an intense synergy between female sex hormones (elevated estrogen and progesterone during pregnancy [chloasma gravidarum], oral contraceptive use, or hormone replacement therapy) and electromagnetic radiation (Ultraviolet A, Ultraviolet B, visible high-energy blue light, and infrared heat).
• Depth Classification (Wood's Lamp): Epidermal melasma (pigment in basal/suprabasal layers; enhances sharply under a Wood's lamp; responsive to topical tyrosinase inhibitors and gentle superficial peeling), Dermal melasma (melanin phagocytosed by dermal melanophages; does not enhance under Wood's lamp; highly resistant to superficial treatment), and Mixed melasma (the most frequent form).
• Esthetic Treatment Caution: Melasma melanocytes are pathologically hyper-excitable. Aggressive chemical peels (such as deep glycolic or TCA), aggressive microdermabrasion, or high thermal energy devices (hot lasers/IPL) generate heat and localized trauma, which reliably triggers explosive rebound hyperpigmentation. Clinical care requires strict daily broad-spectrum SPF 50+, physical zinc oxide blocks, cold treatment protocols, and gentle tyrosinase inhibitors (azelaic acid, kojic acid, tranexamic acid, arbutin, niacinamide).

Post-Inflammatory Hyperpigmentation (PIH)

Post-Inflammatory Hyperpigmentation (PIH) is an acquired pigmentary condition occurring secondary to cutaneous injury, trauma, or inflammatory dermatoses (e.g., acne vulgaris, eczema, psoriasis, chemical peels, burns, or aggressive mechanical extractions):

• Mechanism: During tissue injury, inflammatory mediators such as prostaglandins (PGE2, PGD2), leukotrienes (LTC4, LTD4), and histamine stimulate basal melanocytes to dramatically upregulate tyrosinase transcription. If the basement membrane zone is breached, melanin drops into the papillary dermis, where it is engulfed by dermal macrophages (melanophages), producing stubborn, long-lasting slate-gray or purple hyperpigmentation.
• The Fitzpatrick Factor: While PIH can occur in any skin type, its frequency and severity are dramatically elevated in Fitzpatrick skin phototypes IV, V, and VI (individuals of African, Hispanic, Asian, Mediterranean, and Middle Eastern descent). Estheticians must exercise extreme vigilance when treating skin of color: avoid high-concentration alpha-hydroxy acids, never perform aggressive deep extractions, withhold high-heat modalities, and always prep the skin with topical tyrosinase inhibitors for 2 to 4 weeks prior to any clinical peel.

Solar Lentigines & Ephelides

• Solar Lentigines (Sun Spots / Liver Spots): Flat, discrete, tan-to-dark-brown, circular or irregular macules measuring 2 mm to over 1 cm, located on areas of chronic, cumulative lifetime ultraviolet radiation (face, dorsum of hands, forearms, decollete). Unlike freckles, solar lentigines reflect a localized proliferation of mature melanocytes along the basal layer and do not fade during winter months.
• Ephelides (Freckles): Genetically determined, small (1 to 3 mm), flat macules with distinct borders. They are characterized by a normal number of melanocytes that produce accelerated amounts of melanin in response to UV exposure. Consequently, ephelides darken visibly in summer with sun exposure and fade dramatically during winter.
• Nevus (Mole): A circumscribed benign proliferation or nest of melanocytic cells (nevus cells) that may be congenital or acquired. Nevi can be flat (junctional), raised and fleshy (intradermal), or a combination (compound). Any mole that changes size, shape, or color must be evaluated for malignancy.

---

3. Hypopigmentation & Depigmentation Disorders

Hypopigmentation is the abnormal decrease or total absence of cutaneous melanin pigment, resulting from melanocyte death, enzymatic synthesis failure, or fungal inhibition.

Vitiligo

Vitiligo is an acquired, progressive autoimmune disorder characterized by the targeted, cell-mediated destruction of cutaneous melanocytes by autoreactive cytotoxic CD8+ T-lymphocytes:

• Clinical Presentation: Sharply demarcated, stark, milky-white or chalk-white depigmented macules and patches (complete amelanosis). Lesions frequently present in symmetric distributions across the hands, wrists, perioral and periocular zones, and anogenital regions. Hair follicles within affected vitiliginous patches often lose their pigment as well, a condition termed leukotrichia.
• Clinical Management: Depigmented vitiliginous skin has zero melanin defense against ultraviolet radiation, making it exceptionally vulnerable to severe actinic sunburns and photocarcinogenesis. Clients require continuous broad-spectrum sunscreen application. Esthetic treatments involving aggressive chemical peeling, laser resurfacing, or mechanical trauma are strictly contraindicated because the Koebner phenomenon (development of new vitiligo lesions at sites of cutaneous physical injury) can cause the depigmentation to spread.

Albinism (Oculocutaneous Albinism)

Albinism is a rare, congenital, genetically inherited autosomal recessive disorder characterized by a generalized deficiency or complete absence of melanin pigment throughout the entire skin, hair, and eyes. It is caused by inherited mutations in genes encoding the tyrosinase enzyme (OCA1) or melanosome membrane transport proteins (OCA2). Individuals with albinism present with pale alabaster skin, white or pale yellow hair, pink or translucent pale blue irises, photophobia, nystagmus (involuntary eye oscillation), and severe visual impairment. Because the skin completely lacks photoprotective eumelanin, individuals are at extreme, lifelong risk for severe sunburns and premature cutaneous squamous and basal cell carcinomas.

Leukoderma

Leukoderma is a generalized clinical term referring to an acquired, localized loss of skin pigmentation (achromia or hypopigmentation) resulting from physical trauma, severe thermal or chemical burns, cryotherapy, or chronic skin disease (such as healed post-inflammatory scars). Unlike vitiligo, which is an active systemic autoimmune disorder with spreading bilateral patches, leukoderma is typically static, localized, and directly corresponds to the precise anatomical footprint of a prior physical injury.

Tinea Versicolor (Pityriasis Versicolor)

Tinea versicolor is a common, non-contagious superficial fungal overgrowth caused by dimorphic, lipophilic commensal yeasts belonging to the genus Malassezia (primarily Malassezia globosa and Malassezia furfur):

• Mechanism of Dyschromia: Malassezia naturally resides harmlessly within lipid-rich sebaceous follicles. When ambient temperature, high humidity, and profuse perspiration increase, the yeast shifts from a round yeast form to an invasive mycelial/hyphal form. The fungus metabolizes sebum lipids into azelaic acid and other dicarboxylic acids, which enter basal melanocytes and competitively inhibit the tyrosinase enzyme, blocking normal melanin synthesis.
• Clinical Appearance: Patchy, finely scaling macules predominantly covering the upper chest, back, shoulders, and neck. In sun-exposed skin, the affected fungal zones cannot tan, appearing as hypopigmented (white) patches against tanned skin; on pale, non-tanned skin, lesions often appear fawn-colored, pinkish, or hyperpigmented. It is non-contagious between salon clients, but esthetic steam and occlusive body wraps must be avoided because warmth and moisture exacerbate fungal growth. The client should be referred to a physician for topical antifungal treatment (selenium sulfide or ketoconazole).

---

4. Cutaneous Inflammatory & Vascular Conditions

Cutaneous inflammation represents an activated immune cascade characterized by the classical signs of rubor (redness/erythema), calor (heat), tumor (swelling/edema), and dolor (pain/itching). Four major inflammatory conditions encountered in clinical esthetics are rosacea, contact dermatitis, eczema, and psoriasis.

+-------------------------------------------------------------------------+
|                   CUTANEOUS INFLAMMATORY CONDITIONS                     |
+=========================================================================+
| ROSACEA                       CONTACT DERMATITIS                        |
| - Chronic neurovascular       - Allergic: Type IV Delayed (Nickel, PPD) |
| - Flushing, Telangiectasia,   - Irritant: Direct Barrier Damage (Acids) |
|   Papulopustules (NO comedones)                                         |
| - STEAM / HEAT CONTRAINDICATED                                          |
+-------------------------------------------------------------------------+
| ATOPIC DERMATITIS (ECZEMA)    PSORIASIS                                 |
| - Genetic barrier defect      - Autoimmune T-cell hyperkeratinization   |
| - Filaggrin mutation, xerosis - Rapid 3–4 day cell turnover (vs 28 d)  |
| - Intense pruritus ("itch")   - Silvery micaceous scale on red plaque   |
| - Barrier repair mandatory    - Auspitz sign (pinpoint bleeding)        |
+-------------------------------------------------------------------------+

Rosacea: Vascular Instability & Strict Contraindications

Rosacea is a chronic, progressive neurovascular and inflammatory disorder primarily affecting the central convexities of the face (malar cheeks, nose, central forehead, and chin):

• Etiology: Rosacea involves innate immune dysregulation (overproduction of cathelicidin antimicrobial peptides cleaved into inflammatory fragments), neurovascular hyper-reactivity (abnormal TRPV channels responding to heat and stress), and proliferation of Demodex folliculorum mites inside follicles.
• Subtypes:
  1. Erythematotelangiectatic Rosacea: Characterized by persistent central facial erythema, frequent prolonged flushing episodes, and prominent telangiectasias (couperose veins).
  2. Papulopustular Rosacea: Presents with persistent erythema accompanied by transient crops of inflammatory papules and pustules. Crucial Differential: Unlike acne vulgaris, rosacea never presents with open or closed comedones.
  3. Phymatous Rosacea: Tissue hypertrophy and irregular nodular thickening of connective tissue and sebaceous glands, most frequently presenting as rhinophyma (bulbous enlargement of the nose), predominantly in mature males.
  4. Ocular Rosacea: Involves burning, stinging, gritty foreign-body sensations in the eyes, blepharitis, and conjunctival hyperemia.
• Common Triggers: Exposure to ultraviolet light, high ambient heat, hot baths, directed hot steam, vigorous cardiovascular exercise, emotional stress, alcohol consumption (especially red wine), spicy foods, hot beverages, caffeine, and harsh surfactant cleansers.
• Strict Esthetic Contraindications: Estheticians treating rosacea must avoid all modalities that induce cutaneous vasodilation or mechanical friction. Hot facial steamers directed at the face, aggressive rotary mechanical brushes, thermal paraffin masks, vacuum suction, aggressive microdermabrasion, high-percentage glycolic acid peels, and stimulating petrissage massage are strictly contraindicated. Treatment must be restricted to soothing, anti-inflammatory protocols: cool compresses, gentle non-foaming cleansers, calming ingredients (bisabolol, colloidal oatmeal, licorice extract, green tea, centella asiatica), low-level light therapy (red LED), and strict broad-spectrum mineral zinc oxide SPF.

Contact Dermatitis: Allergic vs. Irritant

Contact dermatitis is an acute or chronic inflammatory reaction triggered by cutaneous exposure to external chemical substances. It is divided into two distinct pathophysiological forms:

• Allergic Contact Dermatitis (ACD): A Type IV cell-mediated delayed hypersensitivity reaction. It requires prior immunological sensitization to a specific chemical hapten. Upon re-exposure, epidermal Langerhans cells present the antigen to sensitized T-lymphocytes, which orchestrate an inflammatory cascade peaking 24 to 72 hours post-exposure. Symptoms include intense pruritus, bright erythema, edema, and closely grouped microvesicles that weep and crust. Common allergens include nickel sulfate (jewelry, facial tools), synthetic fragrances, preservative systems (methylisothiazolinone, formaldehyde-releasers), paraphenylenediamine (PPD in lash/hair dyes), and urushiol oil (poison ivy/oak).
• Irritant Contact Dermatitis (ICD): A non-immunological direct chemical or physical injury to the epidermal barrier. ICD does not require prior sensitization and can occur in anyone exposed to a sufficiently concentrated or harsh chemical. The irritant strips intercellular lipids, denatures keratin proteins, and damages cell membranes. Symptoms appear rapidly (within minutes to hours), manifesting as stinging, burning, erythema, dryness, and painful fissuring. Common culprits in esthetic settings include over-application of high-acid chemical peels (glycolic or TCA without proper neutralization), highly alkaline depilatory creams, strong alcohol degreasers, or repeated wet hand-washing.

Atopic Dermatitis (Eczema)

Atopic dermatitis is a chronic, highly pruritic, relapsing inflammatory skin disease. It is part of the classic atopic triad (atopic dermatitis, allergic rhinitis/hay fever, and asthma):

• Pathophysiology: Rooted in genetic mutations that impair epidermal structural integrity—specifically loss-of-function mutations in the filaggrin gene (FLG). Filaggrin deficiency disrupts stratum corneum protein aggregation and Natural Moisturizing Factor (NMF) synthesis, resulting in severe transepidermal water loss (TEWL), profound xerosis, barrier micro-fissuring, and heightened penetration of environmental allergens and Staphylococcus aureus bacteria.
• Clinical Presentation: Intensely itchy, dry, erythematous patches with excoriations, weeping, and chronic lichenification (thickened, leathery skin with exaggerated markings caused by repetitive rubbing and scratching), commonly localized to the flexural creases (antecubital and popliteal fossae), neck, and hands.
• Esthetic Management: Gentle barrier replenishment with ceramide-rich, cholesterol, and fatty acid physiological emulsions. Avoid hot water, scented cosmetics, mechanical scrubs, and abrasive towels.

Psoriasis: Autoimmune Hyperkeratinization

Psoriasis is a chronic, immune-mediated systemic inflammatory disease with prominent cutaneous manifestations. It is driven by hyperactive T-lymphocytes (Th1 and Th17 cells) that secrete pro-inflammatory cytokines, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-17 (IL-17), and Interleukin-22 (IL-22):

• Accelerated Epidermal Kinetics: Under cytokine stimulation, basal keratinocyte proliferation accelerates exponentially. The normal epidermal turnover transit time from stratum basale to desquamation drops from the normal 28 days down to just 3 to 4 days. Because keratinocytes do not have adequate time to mature, retain their nuclei (parakeratosis), and produce normal barrier lipids, they form massive accumulations of un-shed, hyperkeratotic stratum corneum.
• Plaque Psoriasis (Psoriasis Vulgaris): The most common clinical subtype (approx. 80–90% of cases). Manifests as sharply circumscribed, raised, erythematous plaques covered by thick, adherent, micaceous silvery-white scales. Common sites include extensor surfaces (elbows, knees), the lumbosacral scalp, and nails (pitting and oil-drop signs).
• Classic Dermatological Signs:
  • Auspitz Sign: When an adherent silvery scale is forcibly scraped or peeled away, tiny punctate pinpoint droplets of blood appear immediately on the surface. This occurs because the epidermal rete pegs are dramatically elongated, bringing dilated, tortuous papillary capillaries microscopically close to the thinned suprapapillary epidermal plate.
  • Koebner Phenomenon (Isomorphic Response): The development of characteristic psoriatic lesions at the exact site of cutaneous trauma, surgical incision, burn, or mechanical scratch on previously uninvolved skin.
• Esthetic Scope: Estheticians must never attempt to peel, scrub, or mechanically scrape psoriatic plaques. All aggressive exfoliation modalities over active plaques are contraindicated due to the risk of triggering an Auspitz bleed or Koebner reaction. Refer client to a dermatologist.

---

5. State Board Exam Traps & Clinical Pearls

• Trap: Rosacea vs. Acne Vulgaris: The absolute defining clinical difference on state board examinations is the presence of comedones. Acne vulgaris features open and closed comedones. Rosacea never features comedones—it presents with flushing, telangiectasias, and papulopustules without blackheads or whiteheads.
• Trap: Auspitz Sign Identification: If an exam question asks what diagnostic sign is demonstrated when peeling off a silvery scale produces pinpoint blood droplets, the answer is the Auspitz sign, pathognomonic for psoriasis.
• Trap: PIH and Fitzpatrick Skin Types: High-level state board questions frequently highlight Fitzpatrick skin phototypes IV, V, and VI. Candidates must remember that melanocytes in darker skin types produce larger melanosomes that are distributed individually throughout keratinocytes, making them exceptionally sensitive to trauma and far more prone to severe Post-Inflammatory Hyperpigmentation (PIH).
• Trap: Melasma Treatment Mistake: Candidates often assume high-strength glycolic peels are ideal for melasma. In reality, aggressive heat and chemical trauma cause inflammatory melanocyte activation, resulting in rebound melasma.